Phase I trial of anti-PSMA designer CAR-T cells in prostate cancer: Possible role for interacting interleukin 2-T cell pharmacodynamics as a determinant of clinical response
Junghans, Richard P., Ma, Qiangzhong, Rathore, Ritesh, Gomes, Erica M., Bais, Anthony J., Lo, Agnes S.Y., Abedi, Mehrdad, Davies, Robin A., Cabral, Howard J., Al-Homsi, A. Samer, Cohen, Stephen I.Langue:
english
Journal:
The Prostate
DOI:
10.1002/pros.23214
Date:
June, 2016
Fichier:
PDF, 1.47 MB
english, 2016
File converter
Plus de résultats de recherche
More benefits 
